Skip to main content

Moderna, Inc. cash flow statement

  • MRNA · Nasdaq
  • Biotechnology
  • S&P 500
$223.37−3.45%Close 13 Nov 2026 · Market value $87.52B

In fiscal 2025 (the year to 31 Dec 2025), Moderna, Inc. generated −$1.87B of operating cash flow and −$2.06B of free cash flow, after $192.0M of capital expenditure.

From Moderna, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Moderna, Inc. cash flow statement, annual
USDFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income−$216.2M−$255.9M−$384.7M−$514.0M−$747.0M$12.20B$8.36B−$4.71B−$3.56B−$2.82B−$2.79B
Depreciation & amortization$15.11M$20.54M$24.86M$31.00M$31.00M$232.0M$348.0M$617.0M$185.0M$211.0M$239.0M
Stock-based compensation$39.36M$40.05M$72.56M$81.00M$93.00M$142.0M$226.0M$305.0M$429.0M$483.0M$464.0M
Operating cash flow$66.73M−$331.5M−$330.9M−$459.0M$2.03B$13.62B$4.98B−$3.12B−$3.00B−$1.87B−$1.78B
Operating cash flow margin61.6%−161%−245%—252%73.7%25.9%−45.5%−92.8%−96.3%−70.7%
Capital expenditures$33.14M$58.40M$105.8M$32.00M$68.00M$284.0M$400.0M$707.0M$1.05B$192.0M$185.0M
Acquisitions—————$0.00$0.00$85.00M$0.00$0.00—
Free cash flow$33.59M−$389.9M−$436.6M−$491.0M$1.96B$13.34B$4.58B−$3.83B−$4.05B−$2.06B−$1.97B
Free cash flow margin31.0%−189%−323%—244%72.2%23.8%−55.9%−125%−106%−78.0%
Free cash flow per share$0.55−$6.04−$5.38−$1.48$5.14$30.94$11.01−$10.01−$10.56−$5.31−$4.88
Gross share repurchases———$0.00$0.00$857.0M$3.33B$1.15B$0.00$2.00M—
Stock issuance proceeds——$563.0M$48.00M$179.0M$112.0M$50.00M$25.00M$42.00M$17.00M—
Net share repurchases——−$563.0M−$48.00M−$179.0M$745.0M$3.28B$1.13B−$42.00M−$15.00M—
Cash interest paid$0.00$0.00$3.00M$6.00M$9.00M$14.00M$25.00M$39.00M$24.00M$10.00M—
Free cash flow after SBC−$5.77M−$429.9M−$509.2M−$572.0M$1.87B$13.19B$4.36B−$4.13B−$4.48B−$2.55B−$2.43B

Quarterly

Moderna, Inc. cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$217.0M−$1.18B−$1.28B$13.00M−$1.12B−$971.0M−$825.0M−$200.0M−$826.0M−$1.34B−$782.0M$162.0M
Depreciation & amortization$203.0M$35.00M$40.00M$51.00M$59.00M$38.00M$56.00M$51.00M$66.00M$56.00M$56.00M$61.00M
Stock-based compensation$79.00M$101.0M$112.0M$112.0M$104.0M$115.0M$130.0M$125.0M$113.0M$104.0M$120.0M$127.0M
Operating cash flow$622.0M−$989.0M−$1.27B−$1.57B$825.0M−$1.04B−$919.0M−$847.0M$930.0M−$630.0M−$526.0M−$1.56B
Operating cash flow margin22.1%——−84.1%85.4%——−83.4%137%−162%−363%−119%
Capital expenditures$220.0M$196.0M$182.0M$151.0M$522.0M$117.0M$3.00M$33.00M$39.00M$62.00M$37.00M$47.00M
Acquisitions$0.00$0.00$0.00$0.00$0.00———————
Free cash flow$402.0M−$1.19B−$1.46B−$1.72B$303.0M−$1.15B−$922.0M−$880.0M$891.0M−$692.0M−$563.0M−$1.61B
Free cash flow margin14.3%——−92.2%31.4%——−86.6%131%−178%−388%−122%
Free cash flow per share$1.05−$3.10−$3.79−$4.30$0.79−$2.99−$2.38−$2.26$2.27−$1.75−$1.41−$3.73
Gross share repurchases$0.00$0.00$0.00$0.00$0.00———————
Net share repurchases$0.00$0.00$0.00$0.00$0.00———————
Free cash flow after SBC$323.0M−$1.29B−$1.57B−$1.83B$199.0M−$1.27B−$1.05B−$1.00B$778.0M−$796.0M−$683.0M−$1.73B

The main figures as JSON and plain text. See data and methodology.

MRNA in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.